SMO and breast carcinoma: We used LDE-225 at 0.1 μM, a concentration 100x higher than IC50 for binding of LDE-225 to Smo [54], and found it had no effect on the proliferation of any of the breast cancer cell lines (Figure 6C), suggesting that Smo-mediated signaling is absent in these cells.